Press & Blog

June 1, 2016
Tocagen, our longtime San Diego partner, published results today from a major multi-center study that show that their unique treatment for GBM demonstrated significant extended survival compared to control patients on standard of care. ABC² was the first nonprofit to invest in Tocagen, a clinical-stage, cancer-selective gene therapy company.
Press Releases
May 24, 2016
This summer, Neema Hospitality will once again donate $5 per night at its nine hotel properties in Pennsylvania, West Virginia and Maryland to support ABC²(Accelerate Brain Cancer Cure), a non-profit research organization. BethAnn Telford is the inspiration behind the summer charity promotion. Telford is a brain cancer survivor, Ironman World Champion triathlete and childhood friend of Sandeep Thakrar, President of Neema Hospitality.
May 16, 2016
Last week, the U.S. Food and Drug Administration (FDA) granted "Breakthrough Therapy Designation" for an early-phase brain tumor clinical trial at Duke University that uses re-engineered poliovirus to treat patients with recurrent glioblastoma multiforme (GBM). This past Sunday, CBS "60 Minutes", aired the second segment of their story about this promising trial.